JOHNSON JOHN 4
4 · Xeris Biopharma Holdings, Inc. · Filed Aug 15, 2025
Insider Transaction Report
Form 4
Johnson John H
Director
Transactions
- Sale
Common Stock
2025-08-13$7.32/sh−107,500$786,459→ 833,483 total
Footnotes (1)
- [F1]The price reported in is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.250 to $7.420, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.